The Bombay High Court has quashed the plea filed by Sanofi saying 'superior' packaging cannot be justified for hiking prices of drugs.
According to the court order, the authority for fixing the prices of drugs in the country will remain in the purview of the National Pharmaceutical Pricing Authority.
Earlier, the French pharmaceutical company had said it had taken into account the February 2006 order, which allows a pharmaceutical company to add an amount of INR0.08 per 10 tablets or capsules towards hologram to the latest ceiling price fixed for such formulations, according the Times of India.
Meanwhile, the National Pharmaceutical Pricing Authority had asked the company to deposit INR50m with the authorities for overcharging and reduce the price immediately.
This had led Sanofi to confront the pricing authority in the high court.
